NDC 0641-6146-01 - Dexamethasone Sodium Phosphate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6146
- Requested NDC
- 0641-6146-01
- Package NDCs from labels
- 0641-6146-01, 0641-6146-10, 0641-6146-25
- Manufacturer
- ASCLEMED USA INC. | ASCLEMED USA INC. DBA ENOVACHEM
- Effective date
- 2026-08-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| DEXAMETHASONE - ASCLEMED USA INC. | ASCLEMED USA INC. DBA ENOVACHEM | ASCLEMED USA INC. | ASCLEMED USA INC. DBA ENOVACHEM | 2026-08-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Dexamethasone Sodium Phosphate Injection, USP Rx only | Hikma Pharmaceuticals USA Inc. | 2026-01-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Dexamethasone Sodium Phosphate Injection, USP Rx only | Henry Schein, Inc. | 2025-09-29 | HUMAN PRESCRIPTION DRUG LABEL |
| Dexamethasone Sodium Phosphate Injection, USP Rx only | REMEDYREPACK INC. | 2024-10-04 | HUMAN PRESCRIPTION DRUG LABEL |
| DEXAMETHASONE SODIUM PHOSPHATE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-05-28 | HUMAN PRESCRIPTION DRUG LABEL |
| DEXAMETHASONE SODIUM PHOSPHATE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-30 | HUMAN PRESCRIPTION DRUG LABEL |
| Dexamethasone Sodium Phosphate - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2023-05-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6146-01 | Dexamethasone Sodium Phosphate | 5 mL in 1 VIAL | INJECTION | 5 | 21 | |
| 0641-6146-10 | Dexamethasone Sodium Phosphate | 10 in 1 CARTON | INJECTION | 10 | 21 | |
| 0641-6146-25 | Dexamethasone Sodium Phosphate | 25 in 1 CARTON | INJECTION | 25 | 21 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6146-01 | ML - Milliliter | 0641-6146 | 729ad5b5-3d58-4f75-801a-04c2d6bded64 | 1 | 2017-03-06 |
| 0641-6146-10 | ML - Milliliter | 0641-6146 | d128e26c-4c17-4e5a-a8c9-6294d25f1f0a | 1 | 2024-01-04 |
| 0641-6146-25 | ML - Milliliter | 0641-6146 | 5774f795-5bd6-4205-bb98-b67d1b93879e | 1 | 2017-03-06 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sterile Water | STERILE WATER | Hikma Pharmaceuticals USA Inc. | b20a28b0-7dfa-42eb-9177-ec256d5a5ef7 | 2023-05-08 | Warnings, Adverse reactions | 059QF0KO0R |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Medical Purchasing Solutions, LLC | bbf0f0ee-1891-4f3d-e053-2a95a90a5e18 | 2023-05-04 | Warnings, Adverse reactions | 309696 AI9376Y64P |
| DEXAMETHASONE SODIUM PHOSPHATE | DEXAMETHASONE SODIUM PHOSPHATE | Medical Purchasing Solutions, LLC | 9f69846e-5897-c301-e053-2a95a90a44f1 | 2023-05-03 | Warnings, Adverse reactions | 309696 AI9376Y64P |
| DEXAMETHASONE SODIUM PHOSPHATE | DEXAMETHASONE SODIUM PHOSPHATE | Medical Purchasing Solutions, LLC | 667323ea-5a5e-3465-e053-2a91aa0a1667 | 2023-04-26 | Warnings, Adverse reactions | 1116927 AI9376Y64P |
| Sterile Water | WATER | Civica, Inc. | 3f49eedf-5bf5-4a95-b704-c956d860ca04 | 2023-04-07 | Warnings, Adverse reactions | 059QF0KO0R |
| Treprostinil | TREPROSTINIL | Sandoz Inc | 473297ca-a872-4052-a053-87dc8f0d3c13 | 2023-04-06 | Warnings, Adverse reactions | 059QF0KO0R |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Asclemed USA, Inc. | 2d96d5e8-00bf-406b-b345-f1c31865fe94 | 2023-04-04 | Warnings, Adverse reactions | ANDA084282 1812194 AI9376Y64P |
| Insulin Diluting Medium for NovoLog | WATER INJECTION | Novo Nordisk | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 2023-02-28 | Warnings, Adverse reactions | 059QF0KO0R |
| Rehydrate | AVENA SATIVA, EQUISETUM HYEMALE, HYPERICUM PERFORATUM, ULMUS FULVA, GLYCYRRHIZA GLABRA, SILICEA, PUERARIA LOBATA, CARLSBAD AQUA, ADENOSINUM TRIPHOSPHORICUM DINATRUM, GERMANIUM SESQUIOXIDE, HYDROGEN, OXYGEN, WIESBADEN | ParaDocs All Natural, Inc. | 648fab10-c46b-420f-a42c-6642009d83fb | 2023-01-10 | Warnings | 059QF0KO0R |
| DEXAMETHASONE SODIUM PHOSPHATE | DEXAMETHASONE SODIUM PHOSPHATE | HF Acquisition Co LLC, DBA HealthFirst | 94cb045b-5801-db32-e053-2a95a90a93ef | 2022-12-10 | Warnings, Adverse reactions | 1116927 AI9376Y64P |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | b45e9f1d-9c48-4b46-8541-d846b89540df | 2022-10-26 | Warnings, Adverse reactions | 059QF0KO0R |
| Eye wash | PURIFIED WATER | McKesson | bd089fde-24ba-4de5-e053-2995a90a39bb | 2022-10-18 | Warnings | 059QF0KO0R |
| DEXAMETHASONE SODIUM PHOSPHATE | DEXAMETHASONE SODIUM PHOSPHATE | Asclemed USA, Inc. | ca762fbf-6bf5-4b39-8f40-3fb5f1f77778 | 2022-10-12 | Warnings, Adverse reactions | 1812194 AI9376Y64P |
| Bach Original Flower Remedies Rock Water | WATER | Nelson Bach USA Limited | ea242559-1618-3354-e053-2a95a90a1a95 | 2022-10-03 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | Medical Purchasing Solutions, LLC | e90b47e3-9636-b9ee-e053-2a95a90ad48c | 2022-09-19 | Warnings, Adverse reactions | 059QF0KO0R |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Bausch & Lomb Incorporated | 6bdcefbe-51e3-4ca4-afda-5aeca7b6fa73 | 2022-08-31 | Warnings, Adverse reactions | AI9376Y64P |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | f42ac50f-0ec5-4713-a4c8-99d972d90bed | 2022-06-22 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | e71c6c83-d518-496c-b2ab-efd5987e4783 | 2022-06-09 | Warnings, Adverse reactions | 059QF0KO0R |
| Addiclenz | BETA VULGARIS, BOLDO, CHELIDONIUM MAJUS, PETROSELINUM SATIVUM, TARAXACUM OFFICINALE, ARSENICUM ALBUM, BISPHENOL A, COBALTUM METALLICUM, CUPRUM METALLICUM, GLYPHOSATE, IODIUM, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, SELENIUM METALLICUM, ZINCUM METALLICUM, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYL PARABEN, PROPYL PARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM | Deseret Biologicals, Inc. | e39235ea-2a2f-44a7-92d6-fb1d428ebabd | 2022-05-12 | Warnings | 1Q73Q2JULR |
| ACD-A | ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A | Fenwal, Inc. | 22805f0d-ba58-41ea-b245-19980abcda22 | 2022-02-11 | 1Q73Q2JULR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.